hypertrophy. Furthermore, ET1 mediated its effects indirectly via NE in CM-SN co-cultures through adrenergic receptors and histone deacetylases, resulting in activation of the pro-hypertrophic transcription factor MEF2. In conclusion, sympathetic ETA amplifies ET1 effects on CMs through adrenergic neurotransmission. In accordance to our initial hypothesis, anti-adrenergic therapies may blunt potential beneficial effects of ETAi. These findings call for a personalized strategy to identify patients that could benefit from ETAi. The murine homologue to human chymase, the mouse Mast Cell Protease-4 (mMCP-4), activates the pro-forms of angiotensin-II and endothelin-1 (ET-1) in vivo; both peptides being well-established in cardiovascular diseases. In the present study we postulated that mMCP-4-dependent synthesis of ET-1 plays an important role in the development of atherosclerosis in the Apolipoprotein E knock out mouse model (ApoE KO). Peritoneal mast cells were collected from C56BL/6J wild-type (WT), mMCP-4 KO and ApoE KO mice and their granular contents were assayed for the enzymatic processing of the fluorogenic substrate Suc-Val-Val-Pro-Phe-amidomethylcoumarin. WT and ApoE KO derived samples produced a TY-51469 (specific chymase inhibitor) sensitive fluorescence, but not in mMCP-4 KO samples. Via HPLC detection, a TY-51469-sensitive conversion of big ET-1 to ET-1 (1-31) was monitored in mast cell homogenates. Homogenate samples from ApoE KO mice showed significant increases in ET-1 (1-31) production when compared to extracts from WT mice (milliAU × time (s), WT: 763 ± 124; ApoE KO: 1756 ± 339, n = 7; P = 0.018). Finally, Sudan IV staining of aortas from 27 to 30 week old male mice on chow diet showed that the repression of mMCP-4 in APOE KO mice (APOE/ mMCP-4 dKO) reduced by 65% the atherosclerotic lesion area found in ApoE KO mice (ApoE KO: 7.45 ± 1.31%; ApoE/mMCP-4 dKO: 2.67 ± 0.64%, n = 9-10, P = 0.004). These results suggest an increased contribution role of mMCP-4 in the synthesis of ET-1 in mast cells derived from ApoE KO mice and the pivotal role of that chymase isoform in the development of atherosclerosis. (Funded by CIHR).
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